CID 451881

Xylodapr

Structural Information

Molecular Formula
C10H14N6O3
SMILES
C1[C@H]([C@H](O[C@H]1N2C=NC3=C(N=C(N=C32)N)N)CO)O
InChI
InChI=1S/C10H14N6O3/c11-8-7-9(15-10(12)14-8)16(3-13-7)6-1-4(18)5(2-17)19-6/h3-6,17-18H,1-2H2,(H4,11,12,14,15)/t4-,5-,6-/m1/s1
InChIKey
NOLHIMIFXOBLFF-HSUXUTPPSA-N
Compound name
(2R,3R,5R)-5-(2,6-diaminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

3
References

5
Patents

266.11273 Da
Monoisotopic Mass

-0.5
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 267.12001 157.4
[M+Na]+ 289.10195 167.5
[M-H]- 265.10545 159.1
[M+NH4]+ 284.14655 170.0
[M+K]+ 305.07589 164.2
[M+H-H2O]+ 249.10999 149.4
[M+HCOO]- 311.11093 175.3
[M+CH3COO]- 325.12658 168.4
[M+Na-2H]- 287.08740 159.4
[M]+ 266.11218 156.4
[M]- 266.11328 156.4
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe